I, Ms MP MATSOSO, Director- General for Health, on recommendation of the Pricing Committee and in accordance with Regulation 14
(5) of the Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances published in Government Gazette number 28214 of 11 November 2005, intends to review the appended Guidelines for Pharmacoeconomic Submissions, as published in Government Notice number 36118 of 01 February 2013.